Hospira Opens New Quality Laboratory at North Carolina Plant
Hospira opens a new quality and analytical testing laboratory at its Rocky Mount, North Carolina plant.
Hospira, a provider of injectable drugs and infusion technologies, opened a new quality and analytical testing laboratory at its site in Rocky Mount, North Carolina. The new laboratory is part of a more than $200-million investment at Rocky Mount site, which includes further capital investments. This new quality laboratory will be home to 200 employees, responsible for evaluating and testing more than 450 different products.
The Rocky Mount site, which encompasses more than 1.4 million ft2, provides injectable manufacturing with various technologies, including isolator filling lines and form, fill, and seal operations. The primary product families manufactured at the plant include irrigation and intravenous (I.V.) solutions, renal and cardiovascular care products, therapeutics, local and general anesthesia, analgesia and anti-infectives. Most products are available in a variety of dosage strengths.
Source: Hospira
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.
